Yahoo · Aug 27, 2026
Novo’s 2027 Growth Rebound Faces Fresh Doubts From Deutsche Bank – Even As China Wegovy Milestone Offers Retail Hope
Deutsche Bank said Ziltivekimab is ‘now effectively out of the picture’ after the cardiovascular disease therapy failed a late-stage trial.

